Skip to main content

Table 2 Side effects

From: Response to gefitinib and erlotinib in Non-small cell lung cancer: a retrospective study

  Gefitinib Erlotinib
  Grade 1-2 Grade 3-4 Grade 1-2 Grade 3-4
  No % No % No % No %
Skin rash 40 35 6 5 24 53 2 4
Diarrhea 35 30 8 7 15 33 2 4
Nausea/Vomiting 8 7    7 16 1 2
Fatigue 5 4 2 2 3 7 2 4
Anorexia 4 3 1 1     
Instertitial Lung Disease 3 3